<DOC>
	<DOCNO>NCT01150175</DOCNO>
	<brief_summary>The purpose study determine whether direct endomyocardial injection autologous bone marrow cell effective enhancement neovascularisation patient ischaemic heart failure .</brief_summary>
	<brief_title>Direct Endomyocardial Injection Autologous Bone Marrow Cells Treat Ischaemic Heart Failure</brief_title>
	<detailed_description>Coronary artery disease ( CAD ) remain one leading cause mortality morbidity worldwide . Despite optimal use anti-anginal medication coronary revascularization , large number patient CAD suffer severe symptom disable angina heart failure ( HF ) . Experimental pilot clinical study provide evidence safety potential efficacy strategy intramyocardial transplantation autologous bone marrow ( BM ) cell neovascularisation chronically ischemic myocardium . Nevertheless , possible potent placebo effect symptom observe pilot study highlight need randomize , placebo-controlled group prove clinical efficacy cell base angiogenic therapy treatment severe CAD .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Age 1880 year old Canadian cardiovascular ( CV ) Class IIIV angina and/or NYHA class IIIII HF symptom Received stable `` best '' cardiac medical therapy include longacting nitrate , betablocker , angiotensinconverting enzyme inhibitor without control symptom . Not suitable conventional revascularization refer cardiologist . LVEF &lt; 40 % echocardiography . Recent coronary angiogram ( within last 6 month ) document coronary anatomy insure presence CAD amenable standard revascularization procedure . creatinine less 250mmol/L , normal liver function , normal blood count : WBC , granulocytes ; platelet count , Hb . Reversible perfusion defect single photon emission compute tomography ( SPECT ) Able walk treadmill Hemodynamically stable Subject willing comply specify followup evaluation . All patient give write informed consent . Atrial fibrillation History syncope major ventricular arrhythmia sustain ventricular tachycardia ventricular fibrillation Severe valve disease Aortic mitral valve prosthesis History cancer last 5 year Acute chronic active sepsis , include HIV positive ; hepatitis B C positive Left ventricular wall thickness le 8 mm target territory Left ventricular thrombus and/or spontaneous echocontrast LV detect echocardiography LV aneurysm Severe aortofemoraliliac disease Recent heart attack within last 30 day Hypertrophic restrictive cardiomyopathy Severe comorbidity associate reduction life expectancy le 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>END-HF</keyword>
</DOC>